What is the current FDA consensus on using low dose atropine eye drops for myopia control in pediatric patients, and what are the long term efficacy rates?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What is the current FDA consensus on using low dose atropine eye drops for myopia control in pediatric patients, and what are the long term efficacy rates?
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
FDA low-dose atropine myopia control pediatric FDA approval status 2026 NVK002 Google ↗
low dose atropine myopia control long term efficacy five year LAMP ATOM2 rebound progression rates randomized trial Google ↗
- October 30, 2026 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee · fda.gov
- AAPOS Myopia Task Force Statement on FDA Review of Low-Dose Atropine · aapos.org
- AOA Statement to FDA on Low-Dose Atropine · aoa.org
- Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report · pubmed.ncbi.nlm.nih.gov
- Interpretation of expert consensus on the application of low‐concentration atropine eye drops in the prevention and control of myopia in children and adolescents · pmc.ncbi.nlm.nih.gov
- Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial | Trials | JAMA Ophthalmology · jamanetwork.com
- Low-dose atropine eyedrops no better than placebo for slowing myopia progression · nih.gov
- DODAC to help decide SYD-101’s fate for myopia · bioworld.com
- Discontinuation Approach and Follow-Up of Low-Concentration Atropine for Myopia Progression: Eight-Year Results of the LAMP Randomized Clinical Trial. · pubmed.ncbi.nlm.nih.gov
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA low-dose atropine myopia control pediatric FDA approval status 2026 NVK002 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
low dose atropine myopia control long term efficacy five year LAMP ATOM2 rebound progression rates randomized trial OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |